Is parotidectomy justified in elderly patients with pleomorphic adenoma? A decision analysis model

Gilad Feinmesser, Raphael Feinmesser, Eran Alon, Moshe Leshno

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: The value of parotidectomy in older patients is unclear. This study presents a decision model to help resolve this question. Materials & methods: A Markov model with Monte Carlo simulation was used to compare outcomes in patients of different ages with pleomorphic adenoma of the parotid gland treated by surgery or surveillance. Results: In 30-year-old patients, surgery conferred a 3.5-year gain in life expectancy whereas in 75-year-olds, it was only 0.74 months. The expected rate of malignant transformation at age 30 years was 6.5% after surgery and 26.5% after surveillance; at age 65, corresponding rates were 0.8% and 10.7%. Sensitivity analysis showed that age was the only parameter that significantly contributed to life expectancy. The benefit of surgery was restricted in older patients. Conclusion: Our Markov decision-analysis model suggests that patients older than 65 years with pleomorphic adenoma have a limited survival advantage with surgery compared to surveillance.

Original languageEnglish
Article number102868
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume42
Issue number3
DOIs
StatePublished - 1 May 2021

Keywords

  • Age
  • Markov model
  • Parotid pleomorphic adenoma

Fingerprint

Dive into the research topics of 'Is parotidectomy justified in elderly patients with pleomorphic adenoma? A decision analysis model'. Together they form a unique fingerprint.

Cite this